TAMPA, Fla.--(BUSINESS WIRE)--Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI) notes that its consolidated financial statements for the fiscal year ended September 30, 2006, including its majority-owned subsidiary Biovest International, were audited by Aidman Piser & Co., which issued its opinion and continued the going concern disclaimer. The 2006 disclaimer is consistent with the Company’s 2004 and 2005 financial statements, which reflects the continued developmental stage of Accentia’s consolidated business with Biovest. This information was accurately disclosed in the Company’s Form 10-K filed on December 29, 2006.
